Effect of Total Glucosides of Paeony on Imiquimod-Induced Psoriatic Skin Lesions by Regulating VEGF

References

• Alex Anand D, Harishchander A, Jason UB. An integrated network analysis of psoriasis: a novel approach to disease pathology. Asian J Pharm Clin Res. 2015;8(3):176–178.
   Google Scholar
• Bagchi S, Zhang H, He Y, Wang CR. Self-lipid specific T cells, restricted by CD1b, contribute to the development of hyperlipidemia-associated skin inflammation (BA11P.133). J Immunol. 2015;194(1 Sup):184.15.
   Google Scholar
• Gisondi P, Dalle Vedove C, Girolomoni G. Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy. Dermatol Ther. 2014;4(1):1–9. doi:10.1007/s13555-014-0042-5
   Google Scholar
• Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. J Am Med Assoc. 2020;323(19):1945–1960. doi:10.1001/jama.2020.4006
   PubMed Web of Science ®Google Scholar
• Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis. 2007;10(3):149–166. doi:10.1007/s10456-007-9074-0
   PubMedGoogle Scholar
• Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. doi:10.3390/ijms20061475
   PubMed Web of Science ®Google Scholar
• Grän F, Kerstan A, Serfling E, Goebeler M, Muhammad K. Current developments in the immunology of psoriasis. Yale J Biol Med. 2020;93(1):97–110.
   PubMed Web of Science ®Google Scholar
• Henno A, Blacher S, Lambert CA, et al. Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis. J Dermatol Sci. 2010;57(3):162–169. doi:10.1016/j.jdermsci.2009.12.006
   PubMed Web of Science ®Google Scholar
• Marina ME, Roman II, Constantin A-M, Mihu CM, Tătaru AD. VEGF involvement in psoriasis. Med Pharm Reports. 2015;88(3):247–252. doi:10.15386/cjmed-494
   Google Scholar
• Huggenberger R, Ullmann S, Proulx ST, Pytowski B, Alitalo K, Detmar M. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med. 2010;207(10):2255–2269. doi:10.1084/jem.20100559
   Web of Science ®Google Scholar
• Hvid H, Teige I, Kvist PH, Svensson L, Kemp K. TPA induction leads to a Th17-like response in transgenic K14/ VEGF mice: a novel in vivo screening model of psoriasis. Int Immunol. 2008;20(8):1097–1106. doi:10.1093/intimm/dxn068
   PubMed Web of Science ®Google Scholar
• Yalçin B, Tezel GG, Arda N, Erman M, Alli N. Vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and cyclooxygenase-2 expression in psoriasis. Anal Quant Cytol Histol. 2007;29(6):358–364.
   Google Scholar
• Dvorak AM, Feng D. The vesiculo-vacuolar organelle (VVO): a new endothelial cell permeability organelle. J Histochem Cytochem. 2001;49(4):419–432. doi:10.1177/002215540104900401
   PubMed Web of Science ®Google Scholar
• Nofal A, Al-Makhzangy I, Attwa E, Nassar A, Abdalmoati A. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control. J Eur Acad Dermatology Venereol. 2009;23(7):803–806. doi:10.1111/j.1468-3083.2009.03181.x
   PubMed Web of Science ®Google Scholar
• Lee JH, Cho EY, Namkung JH, et al. Single-nucleotide polymorphisms and haplotypes in the VEGF receptor 3 gene and the haplotype GC in the VEGFA gene are associated with psoriasis in Koreans. J Invest Dermatol. 2008;128(6):1599–1603. doi:10.1038/sj.jid.5701204
   PubMed Web of Science ®Google Scholar
• Zablotna M, Sobjanek M, Nedoszytko B, et al. Association of psoriasis with the VEGF gene polymorphism in the northern Polish population. J Eur Acad Dermatology Venereol. 2013;27(3):319–323. doi:10.1111/j.1468-3083.2011.04393.x
   Web of Science ®Google Scholar
• Jiang H, Li J, Wang L, et al. Total glucosides of paeony: a review of its phytochemistry, role in autoimmune diseases, and mechanisms of action. J Ethnopharmacol. 2020;258:112913. doi:10.1016/j.jep.2020.112913
   PubMed Web of Science ®Google Scholar
• Zheng Q, Jiang WC, Sun XY, et al. Total glucosides of paeony for the treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. Phytomedicine. 2019;62:152940. doi:10.1016/j.phymed.2019.152940
   PubMed Web of Science ®Google Scholar
• Yu C, Fan X, Li Z, Liu X, Wang G. Efficacy and safety of total glucosides of paeony combined with Acitretin in the treatment of moderate-to-severe plaque psoriasis: a Double-blind, randomised, placebo-controlled trial. Eur J Dermatol. 2017;27(2):150–154. doi:10.1684/ejd.2016.2946
   Web of Science ®Google Scholar
• Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 2003;102(1):161–168. doi:10.1182/blood-2002-12-3793
   PubMed Web of Science ®Google Scholar
• Li B, He S, Liu R, et al. Total glucosides of paeony attenuates animal psoriasis induced inflammatory response through inhibiting STAT1 and STAT3 phosphorylation. J Ethnopharmacol. 2019;243:112121. doi:10.1016/j.jep.2019.112121
   PubMed Web of Science ®Google Scholar
• Li XQ, Chen Y, Dai GC, Zhou BB, Yan XN, Tan RX. Abietic acid ameliorates psoriasis-like inflammation and modulates gut microbiota in mice. J Ethnopharmacol. 2021;272:113934.
   Web of Science ®Google Scholar
• Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020;207:107452. doi:10.1016/j.pharmthera.2019.107452
   PubMed Web of Science ®Google Scholar
• Guan XNW. Total glucosides of Paeonia’s influence on T-cell subgroup in peripheral blood of common plaque psoriasis. Henan Tradit Chinese Med. 2010;30:455–456.
   Google Scholar
• Simonetti O, Lucarini G, Goteri G, et al. VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study. Int J Immunopathol Pharmacol. 2006;19(4):751–760. doi:10.1177/039463200601900405
   PubMed Web of Science ®Google Scholar
• Mavropoulos A, Rigopoulou EI, Liaskos C, Bogdanos DP, Sakkas LI. The role of p38 mapk in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Dev Immunol. 2013;2013:569751. doi:10.1155/2013/569751
   PubMedGoogle Scholar